Skip to main navigation Skip to search Skip to main content

Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)

  • K Berencsi
  • , A Sami
  • , M S Ali
  • , K Marinier
  • , N Deltour
  • , S Perez-Gutthann
  • , L Pedersen
  • , P Rijnbeek
  • , J Van der Lei
  • , F Lapi
  • , M Simonetti
  • , C Reyes
  • , M C J M Sturkenboom
  • , D Prieto-Alhambra*
  • *Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The original version of this article, published on 26 November 2019 contained a mistake. An author’s name was misspelled. The correct author name reads as follows: Susana Perez-Gutthann. The original article has been corrected.

Original languageEnglish
Pages (from-to)799
Number of pages1
JournalOsteoporosis International
Volume31
Issue number4
Early online date5 Feb 2020
DOIs
Publication statusPublished - 1 Apr 2020

Fingerprint

Dive into the research topics of 'Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)'. Together they form a unique fingerprint.

Cite this